CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case–control study

The aim of this study was to assess whether the CYP2C9*2 and/or *3 variants might modify the risk for NSAID-related upper gastrointestinal bleeding (UGIB) in NSAID users. PATIENTS AND METHODS: We conducted a multicenter, case–control study in which cases were patients aged more than 18 years with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueiras, Adolfo, Estany-Gestal, Ana, Aguirre, Carmelo, Ruiz, Borja, Vidal, Xavier, Carvajal, Alfonso, Salado, Inés, Salgado-Barreira, Angel, Rodella, Luca, Moretti, Ugo, Ibáñez, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704657/
https://www.ncbi.nlm.nih.gov/pubmed/26544900
http://dx.doi.org/10.1097/FPC.0000000000000186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704657/
https://www.ncbi.nlm.nih.gov/pubmed/26544900
http://dx.doi.org/10.1097/FPC.0000000000000186

Ejemplares similares